Recently developed a brand new drug for asthma may not only reduce symptoms, but also to make better pulmonary function of the patient. Medicine created through the cooperation of two major pharmaceutical companies with a worldwide reputation. The test drug was determined that his admission to 87 percent reduces asthma compared to people who took placebo. In a phased study drug was attended by over one hundred people suffering from asthma in moderate and severe.
During the experiment, the participants were divided into 2 groups, one of which is for three months received a new drug, and the second placebo. Among the participants of the first group during the study there were three of asthma attack, while the second group was awarded a whopping 23 cases. It should be noted that in the past, many scientists have tried to create a cure for asthma, but all their attempts were unsuccessful.
New drug for its effect of blocking two proteins: interleukin-13 and interleukin-4, play an important role in the occurrence of asthma and other allergic diseases. The drug affects the mechanisms that lead to the development of the disease, and also copes with the cleansing of the respiratory tract. Meanwhile, before the release of medication on sale got to spend a few more large-scale studies in order to define the optimal dose for each group of patients, including children, and also to prove that the drug is not harmful.